EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Genotypic‐Phenotypic Correlations in Non‐ HbE β‐Thalassemia Intermedia: A Geographic Systematic Review

Kavindya Fernando, Shiromi Perera, Anuja Premawardhena

Molecular Genetics & Genomic Medicine · 2026-11 · 14 (11)

DOI: 10.1002/mgg3.70330 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Background β‐thalassemia intermedia (β‐TI), now more commonly classified within the spectrum of non‐transfusion‐dependent thalassemia (NTDT), is a clinically heterogeneous disorder in which disease severity is determined not only by β‐globin mutations but also by co‐inherited genetic modifiers that vary across populations. These include α‐globin gene alterations, fetal haemoglobin (HbF)‐inducing polymorphisms, and other regulatory loci that influence globin chain balance. Methods A systematic review was conducted in accordance with PRISMA 2020 guidelines. PubMed was searched from inception to May 2026, supplemented by citation tracking and manual screening. Studies reporting genotype–phenotype correlations in β‐TI were included. Data were synthesized qualitatively by geographic region. Results Twenty‐one studies were included. The available evidence suggests Mediterranean populations are primarily influenced by mild β‐globin mutations. In Middle Eastern populations, HbF‐inducing polymorphisms, particularly the XmnI variant, played a prominent role, often mitigating severe genotypes. Among the included studies, Asian populations exhibited the greatest molecular heterogeneity, with α‐globin gene dosage alterations, including triplication, contributing substantially to disease expression. Conclusion The available evidence suggests regional differences in the contribution of genetic modifiers to the β‐thalassemia intermedia phenotype. Recognition of these patterns may improve understanding of genotype–phenotype variability and may help inform future approaches to diagnosis, prognostication, and individualized therapeutic strategies.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →